ArticleCancers2022

The Optimal Therapy after Progression on Immune Checkpoint Inhibitors in MSI Metastatic Gastrointestinal Cancer Patients: A Multicenter Retrospective Cohort Study.

Mifen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.